About 1 000 reports

Forecasts by Product (Lucentis, Eylea, Avastin, Visudyne, Others), by Indication (AMD, Diabetic, Macular, Edema, Diabetic, Retinopathy, Retinal Vein, Occlusion, Others), by End-User (Hospital Pharmacy, Retail, Pharmacy, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery...

  • Eye Disease
  • Ophthalmology
  • World

Retinal Diseases

  • Clinical Trial
  • South Carolina
  • Illinois
  • Medical Devices Sales

Jun ##: Aldeyra Therapeutics receives orphan medicinal product designation from the European Commission for ADX- ## Retinal Disease Program .................................................................................................................................................

  • Drug Development
  • World
  • Drug Approval
  • Health Provider Density

RETINAL DISEASE TREATMENT

  • LED
  • Eye Disease
  • ICT
  • Biotechnology
  • APAC
  • Europe
  • Direct Sales
  • Number Of Enterprises

Antisense RNAi Oligonucleotides to Inhibit HIF-## Alpha for Oncology and Retinal Disease – Drug Profile

  • Pharmaceutical
  • Eye Disease
  • World
  • Vessel Fleet
  • Energy Supply

The company‟s product pipeli ne includes Reproxalap, an al dehy de trap for the treatment of all ergic conjuncti vitis and dry eye disease; ADX-## to treat proli ferati ve vitreoretinopat hy and intraocular lymphoma; and A DX-##/##X for the treatm ent of retinal disease.

  • Pharmaceutical
  • Drug Development
  • Therapy
  • World
  • Drug Approval
  • Health Provider Density

Table ##: Intelligent OCT Retinal Disease Screening System - Product Status

  • Clinical Trial
  • Texas
  • Travis County
  • California
  • Cook County
  • Health Provider Density
  • Medical Technology Density

THE GROWING PREVALENCE OF RETINAL DISEASES IS EXPECTED TO BOOST MARKET GROWTH

  • Ophthalmology
  • World
  • APAC
  • North America
  • Europe
  • Energy Consumption

Table ##: Intelligent OCT Retinal Disease Screening System - Product Description

  • Clinical Trial
  • CT Scan
  • United States
  • Texas
  • Japan
  • Illinois
  • Microscopes And Microscope Parts Sales
  • Medical Devices Sales

OCU-## is under development for the treatment of inherited degenerative retinal diseases (IRDs) such as NR##E##, CEP##, PDE##B and RHO mutation-associated recessive retinal degeneration, Leber Congenital Amaurosis (LCA), Bardet-Biedl Syndrome (BBS), enhanced S-cone syndrome and rhodopsin mutations associated retinitis pigmentosa and other retinal degenerations.

  • Drug Development
  • World
  • France
  • Health Provider Density

Retinal Surgery Device Market, Global Forecast, Impact of COVID-19, Industry Trends, by Product, Growth, Opportunity Company Analysis Retinal diseases vary widely, but most retinal diseases cause visual symptoms and can affect any part of the retina. The various equipment and accessories used for...

  • Surgical Equipment
  • Ophthalmology
  • Eye Disease
  • World

Global Retinal Drugs Market 2021-2025 The analyst has been monitoring the retinal drugs market and it is poised to grow by $ 6.28 bn during 2021-2025, progressing at a CAGR of 6% during the forecast period. Our report on retinal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers,...

  • Eye Disease
  • Marketing Research
  • Biotech Diagnostics
  • World

Antisense RNAi Oligonucleotide to Inhibit ICAM-## for Oncology and Retinal Diseases – Drug Profile

  • Pharmaceutical
  • Healthcare
  • Eye Disease
  • Cancer
  • Gene Therapy
  • World
  • China
  • Pharmaceutical Registrations

OCU-## is under development f or the treatment of inherited degenerative retinal diseases (IRDs) such as NR##E##, CEP## and RHO mutat ion-associated recessive retinal degeneration, Leber Congenital Amaurosis (LCA), Bardet-Biedl Syndrome (BBS), enhanced S-cone syndrome and rhodopsin mutations associated retinitis pigmentosa and other retinal degenerations.

  • Therapy
  • Gene Therapy
  • World

INTRODUCTION According to the World Health Organization (WHO), more than 2.2 billion individuals across the world suffer from some degree of vision impairment caused due to various ophthalmic disorders, such as glaucoma, trachoma, cataract, diabetic retinopathy and wet age-related macular degeneration. Around 50% of the...

  • Ocular Drug Delivery
  • Drug Delivery
  • Eye Disease
  • Ophthalmology
  • World
  • APAC

Further, in December 2020, ONL Therapeutics closed rounds of series funding (US$ ## million) for its ONL## peptide candidate for retinal diseases.

  • Therapy
  • World
  • APAC
  • Europe
  • Middle East
  • Africa
  • Central America
  • Cancer Incidence
  • Cause-Specific Mortality Rate

OCU-## is under development for the treatment of inherited degenerative retinal diseases (IRDs) such as NR##E## and CEP## mutations associated recessive retinal degeneration, Leber Congenital Amaurosis (LCA), Bardet-Biedl Syndrome (BBS), enhanced S-cone syndrome and rhodopsin mutations associated retinitis pigmentosa and other retinal degenerations.

  • Therapy
  • Gene Therapy
  • Drug Development
  • World

Medical device manufacturers are increasingly incorporating artificial intelligence (AI) in their systems with the aim to better assist healthcare providers and also improve care provided to the patients.AI systems have the ability to acquire data, deploy logical rules for processing the data, generate reasonable solutions and automatically...

  • Artificial Intelligence
  • Medical Device
  • Health Care Provider

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type, By Region, And Segment Forecasts, 2020 - 2027 The global gene therapy market size is expected to reach USD 6.6 billion by 2027, at a CAGR of 16.6% over the forecast period....

  • Gene Therapy
  • World
  • North America
  • United States
  • Drug Approval

Ophthalmic Drugs Market by Indication (Dry Eye, Glaucoma, Infection/Inflammation/Allergy, Retinal Disorders, and Others), Type (Prescription Drugs and Over-the-counter-Drugs), Dosage Form (Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semi-Solid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, and Other Ophthalmic...

  • Ophthalmic Solution
  • Eye Disease
  • Ophthalmology
  • World
  • APAC
  • Eye Diseases Prevalence

BMC Public Health published a study, in 2019, on the evaluation of costs and benefits of bevacizumab for the treatment of retinal diseases that involved macular degeneration.

  • Eye Disease
  • Ophthalmology
  • Healthcare
  • Pharmaceutical
  • APAC
  • Europe
  • Health Expenditure
  • Elderly Population

##.## Europe Inherited Retinal Disease Gene Therapy Market by Value

  • Gene Therapy
  • World
  • Health Expenditure
  • Chronic Disease Prevalence

##.## OCT/FUNDUS IMAGING S YSTEMS HAVE WIDE APP LICATIONS IN RETINAL DISEASE DIAG NOSIS

  • Diagnostic Imaging
  • CT Scan
  • APAC
  • Europe
  • North America
  • Latin America
  • Medical Technology Density
  • Drug Approval

Retinal diseases can affect any part of the retina.

  • Eyewear
  • World
  • Eye Diseases Prevalence
  • Drug Approval

Table ##: Retinal Disease Evaluation Device - Product Description

  • Clinical Trial
  • United States
  • California
  • Health Provider Density
  • Outpatient Visits

This enables the company to initiate clinical testing of SF-## in both wet Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) patients, two retinal diseases that are among the leading causes of blindness globally.

  • Therapy
  • Drug Development
  • Protein Therapy
  • World
  • Stem Cell Transplantation
  • Diagnostic Imaging Density

Major players in the ophthalmic medical lasers market are Alcon Laboratories Inc, Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co. Ltd, Lumenis Ltd, and Johnson & Johnson Surgical Vision Inc. The global ophthalmic medical lasers...

  • Ophthalmology
  • Eye Disease
  • France
  • Australia
  • Japan
  • United States
  • World
  • South Australia
  • Health Provider Density

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....

  • Eye Disease
  • World

Major players in the bacterial & plasmid vectors market are Sigma-Aldrich Inc., ATUM, QIAGEN, Promega Corporation, Thermo Fisher Scientific, Inc., GenScript Biotech Corporation, Takara Bio Inc., IBA GmbH, Bio-Rad Laboratories, and New England Biolabs. The global bacterial & plasmid vectors market is expected to grow from $0.34 billion...

  • Gene Therapy
  • World
  • France

Major players in the bacterial and plasmid vectors market are Sigma-Aldrich Inc., ATUM, QIAGEN, Promega Corporation, Thermo Fisher Scientific, Inc., GenScript Biotech Corporation, Takara Bio Inc., IBA GmbH, Bio-Rad Laboratories and New England Biolabs. The global bacterial and plasmid vectors market is expected to decline from $0.36...

  • Gene Therapy
  • World
  • France